{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:44:09Z","timestamp":1772192649377,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jdiacomp.2006.01.001","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T20:09:32Z","timestamp":1141243772000},"page":"113-120","source":"Crossref","is-referenced-by-count":53,"title":["Hepatitis C infection and diabetes"],"prefix":"10.1016","volume":"20","author":[{"given":"Hiroshi","family":"Noto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2006.01.001_bib1","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1097\/01.ASN.0000145439.48387.BF","article-title":"Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus","volume":"15","author":"Abbott","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","article-title":"Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population","volume":"21","author":"Allison","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.hep.2003.09.012","article-title":"Impaired IRS-1\/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11892-004-0023-7","article-title":"Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights","volume":"4","author":"Bahtiyar","year":"2004","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jhep.2000.8270","article-title":"Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation","volume":"32","author":"Bigam","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1097\/01.ASN.0000012382.97168.E0","article-title":"Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus","volume":"13","author":"Bloom","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib7","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/diacare.28.6.1518","article-title":"Second World Congress on the Insulin Resistance Syndrome: Insulin resistance syndrome and nonalcoholic fatty liver disease","volume":"28","author":"Bloomgarden","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib8","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/diacare.28.8.2061","article-title":"Prevalence of body iron excess in the metabolic syndrome","volume":"28","author":"Bozzini","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/bmj.313.7049.92a","article-title":"Rapidly reversible increase in insulin requirement with interferon","volume":"313","author":"Campbell","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.510300416","article-title":"Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection","volume":"30","author":"Caronia","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-125-6-199609150-00035","article-title":"Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C","volume":"125","author":"Chedin","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/diabetes.49.5.810","article-title":"Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa\/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase","volume":"49","author":"Cheung","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib14","doi-asserted-by":"crossref","first-page":"24484","DOI":"10.1074\/jbc.M202449200","article-title":"WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP\/F-1 mice","volume":"277","author":"Chou","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2337\/diacare.22.5.756","article-title":"Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study","volume":"22","author":"de Marco","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/BF02087923","article-title":"Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis","volume":"41","author":"di Cesare","year":"1996","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib17","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1572-0241.2001.04054.x","article-title":"The role of diabetes in hepatocellular carcinoma: A case-control study among United States Veterans","volume":"96","author":"El-Serag","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1185\/030079905X38141","article-title":"Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients","volume":"21","author":"Elsammak","year":"2005","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","article-title":"Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis","volume":"340","author":"Fabris","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0168-8278(98)80328-0","article-title":"Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis","volume":"28","author":"Fabris","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib21","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.2337\/diacare.22.12.1978","article-title":"Diabetes and serum ferritin concentration among U.S. adults","volume":"22","author":"Ford","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib22","first-page":"526","article-title":"Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection","volume":"32","author":"Fraser","year":"1996","journal-title":"Israel Journal of Medical Sciences"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.289.10.1245-b","article-title":"Hepatitis C virus and atherosclerosis in patients with type 2 diabetes","volume":"289","author":"Fukui","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1464-5491.1995.tb00466.x","article-title":"High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests","volume":"12","author":"Gray","year":"1995","journal-title":"Diabetic Medicine"},{"issue":"Suppl. 3","key":"10.1016\/j.jdiacomp.2006.01.001_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2362.32.s3.4.x","article-title":"Identifying the links between obesity, insulin resistance and beta-cell function: Potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes","volume":"32","author":"Greenberg","year":"2002","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib26","first-page":"544","article-title":"High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study","volume":"20","author":"Grimbert","year":"1996","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(94)90276-3","article-title":"Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia","volume":"343","author":"Guerci","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-139-10-200311180-00029","article-title":"Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people","volume":"139","author":"Haap","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hep.510290246","article-title":"Diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Hadziyannis","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0168-8278(03)00463-X","article-title":"In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: Implications for therapy","volume":"39","author":"Hickman","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI117495","article-title":"Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha","volume":"94","author":"Hotamisligil","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8278(03)00479-3","article-title":"Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: A retrospective study on a large cohort of patients in the United States","volume":"40","author":"Hu","year":"2004","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib32","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]","volume":"125","author":"Hui","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib34","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/jcp.47.12.1112","article-title":"Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection","volume":"47","author":"Hussain","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0168-8278(88)80004-7","article-title":"Interferon induces insulin resistance in patients with chronic active hepatitis C","volume":"28","author":"Imano","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib36","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1572-0241.1999.01083.x","article-title":"Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection","volume":"94","author":"Itoh","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9610(05)80252-1","article-title":"Non-insulin-dependent diabetes mellitus and elevated serum ferritin level","volume":"7","author":"Kaye","year":"1993","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.20092","article-title":"New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection","volume":"10","author":"Khalili","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI7917","article-title":"Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2","volume":"105","author":"Kido","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/qjmed\/hci001","article-title":"TNF-\u03b1, chronic hepatitis C and diabetes: A novel triad","volume":"98","author":"Knobler","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4065\/75.4.355","article-title":"Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection","volume":"75","author":"Knobler","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004836-199801000-00009","article-title":"Higher incidence of diabetes in liver transplant recipients with hepatitis C","volume":"26","author":"Knobler","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000007778","article-title":"Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection","volume":"62","author":"Konrad","year":"2000","journal-title":"Digestion"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2362.2000.00608.x","article-title":"Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha","volume":"30","author":"Konrad","year":"2000","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/en.130.1.43","article-title":"Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output","volume":"130","author":"Lang","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.510280531","article-title":"Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral RNA in various tissues","volume":"28","author":"Laskus","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib46","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/diacare.27.11.2669","article-title":"Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection","volume":"27","author":"Lecube","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib47","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/diacare.27.5.1171","article-title":"High prevalence of glucose abnormalities in patients with hepatitis C virus infection: A multivariate analysis considering the liver injury","volume":"27","author":"Lecube","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/gast.2002.31001","article-title":"Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus","volume":"122","author":"Lerat","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(94)91035-9","article-title":"Exacerbation of type 2 diabetes mellitus during interferon-alfa therapy for chronic hepatitis B","volume":"343","author":"Lopes","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib81","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1046\/j.1440-1746.2003.03179.x","article-title":"Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection","volume":"18","author":"Maeno","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib82","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: A feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib83","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marinos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib52","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0016-5085(95)90694-0","article-title":"Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection","volume":"108","author":"Marinos","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib53","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2337\/diacare.28.4.940","article-title":"Hepatitis C virus infection and human pancreatic beta-cell dysfunction","volume":"28","author":"Masini","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2002","journal-title":"The American Journal of the Medical Sciences"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib55","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00000441-200502000-00006","article-title":"Post-transplantation diabetes mellitus","volume":"329","author":"Mora","year":"2005","journal-title":"Am J Med Sci"},{"issue":"Pt 7","key":"10.1016\/j.jdiacomp.2006.01.001_bib58","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib59","first-page":"1480","article-title":"Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection","volume":"91","author":"Ozyilkan","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib85","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib60","doi-asserted-by":"crossref","first-page":"29911","DOI":"10.1074\/jbc.272.47.29911","article-title":"A molecular basis for insulin resistance. Elevated serine\/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation","volume":"272","author":"Paz","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-8278(01)00143-X","article-title":"Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C","volume":"35","author":"Petit","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mlc.2001.111515","article-title":"Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: Effect of treatment with interferon","volume":"137","author":"Piquer","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","article-title":"Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib64","doi-asserted-by":"crossref","first-page":"38990","DOI":"10.1074\/jbc.M006490200","article-title":"Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo","volume":"275","author":"Previs","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib65","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0168-8278(03)00456-2","article-title":"Fibrogenic impact of high serum glucose in chronic hepatitis C","volume":"39","author":"Ratziu","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib86","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diabetes.51.5.1319","article-title":"Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-kappaB activation by TNF-alpha is obligatory","volume":"51","author":"Ruan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1359-6101(03)00052-2","article-title":"Insulin resistance in adipose tissue: Direct and indirect effects of tumor necrosis factor-alpha","volume":"14","author":"Ruan","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/diacare.7.3.248","article-title":"Liver function tests in diabetic patients","volume":"7","author":"Salmela","year":"1984","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib68","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1572-0241.2003.07640.x","article-title":"Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome","volume":"98","author":"Sanyal","year":"2003","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0168-8227(95)01188-9","article-title":"Onset of diabetes with high titer anti-GAD antibody after IFN therapy for chronic hepatitis","volume":"30","author":"Shiba","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib70","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib71","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/diacare.19.9.998","article-title":"High prevalence of hepatitis C virus infection in diabetic patients","volume":"19","author":"Simo","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib72","first-page":"335","article-title":"Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C","volume":"28","author":"Tanaka","year":"1997","journal-title":"J Med"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0168-8227(94)90124-4","article-title":"Occurrence of IDDM during interferon therapy for chronic viral hepatitis","volume":"23","author":"Waguri","year":"1994","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib74","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","article-title":"Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients","volume":"3","author":"Woodward","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib75","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/MCB.16.6.3074","article-title":"Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice","volume":"16","author":"Yamauchi","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1572-0241.2005.40429.x","article-title":"Chronic hepatitis C and type II diabetes mellitus: A prospective cross-sectional study","volume":"100","author":"Zein","year":"2005","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2006.01.001_bib77","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-8278(99)80060-9","article-title":"Soluble tumor necrosis factor receptors in chronic hepatitis C: A correlation with histological fibrosis and activity","volume":"30","author":"Zylberberg","year":"1999","journal-title":"Journal of Hepatology"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872706000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872706000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T22:15:28Z","timestamp":1736288128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872706000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1056872706000055"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2006.01.001","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}